Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:51:05.852Z.
Calculation as of: 2026-10-06T21:51:05.852Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c882cca81b2c0fe2c09916b57b0a50c93804d18514abf2397940823ad07c5bd
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
CAMP4 Therapeutics Corporation
Market Cap
$248.50M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$247.62M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$247.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$249.79M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$241.94M
Operating Cash Flow Yield
N/A
TTM Avg
1.55%
3Y Avg
1.55%
5Y Avg
2.54%
Market Cap
$241.39M
Operating Cash Flow Yield
N/A
TTM Avg
12.52%
3Y Avg
12.52%
5Y Avg
12.52%
Market Cap
$241.34M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$255.88M
Operating Cash Flow Yield
2.34%
TTM Avg
4.24%
3Y Avg
3.35%
5Y Avg
2.66%
Market Cap
$256.47M
Operating Cash Flow Yield
N/A
TTM Avg
21.89%
3Y Avg
21.13%
5Y Avg
21.13%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $248.50M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | N/A | N/A | N/A | N/A |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | N/A | N/A | N/A | N/A |
| Upstream Bio, Inc. (UPB)vs › | $249.79M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A | 1.55% | 1.55% | 2.54% |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | N/A | 12.52% | 12.52% | 12.52% |
| Quantum-Si incorporated (QSI)vs › | $241.34M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 2.34% | 4.24% | 3.35% | 2.66% |
| AC Immune S.A. (ACIU)vs › | $256.47M | N/A | 21.89% | 21.13% | 21.13% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | 3.96% | 3.96% | 3.96% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
